- Motley Fool•4 days ago
Endo International, Horizon Pharma, and Valeant Pharmaceuticals have all run into a proverbial buzz saw this year. But these beaten-down specialty pharma stocks may now be too cheap too ignore.
- Market Realist•13 days ago
Horizon operates through three segments: Primary Care, Orphan Drugs, and Rheumatology. It proposes to become an orphan disease drug company by fiscal 2020.
Horizon Pharma plcNasdaqGS
After hours: 18.730.00 (0.00%) as of 4:34 PM EDT
|Bid||18.20 x 400|
|Ask||18.73 x 100|
|52wk Range||12.86 - 38.46|
|Day's Range||18.43 - 19.01|
|Avg Vol (3m)||4,024,250|
As of 4:00 PM EDT. Market closed.